On July 8, 2025, the Society for Immunotherapy of Cancer (SITC) in partnership with the National Cancer Institute (NCI) held the fifth computational immuno-oncology webinar of series 5. This webinar described four approaches for predicting patients’ response to checkpoint immunotherapy recently developed in Dr. Ruppin’s lab, including: (1) predicting patients’ response to the tumor bulk transcriptome, (2) predicting response directly from the blood via simple routine lab tests and the tumor mutational burden, (3) predicting patients’ immunotherapy response from the tumor histopathological images, and (4) building predictors of the tumor microenvironment and developing spatially-grounded biomarkers of treatment response. It concluded by discussing challenges and the road ahead.
View the webinar for free on-demand HERE.